fda and compounded semaglutide Hims & Hers stock falls 25% as curtails GLP-1s The FDA Warns of the

Am J Clin Nutr 2009

Both are safe for long term use

Focusing on a customer-centric approach, M.S

Semaglutide (Wegovy, Ozempic) produces 14.9% average weight loss and has the broadest FDA-approved indications, including cardiovascular risk reduction

A community you can count on Join the thousands of people who have said yes to real support Check your eligibility in under 2 minutes Own your wellness with personalized GLP-1 care 125 k OrderlyMeds customers that reported weight loss with us * 1M + Total pounds lost by OrderlyMeds customers * 15 lbs Average weight loss on our 3-month starter plan * *Based on OrderlyMeds customer data collected from January 1, 2024 October 31, 2025